The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Succinate dehydrogenase (SDH)‐deficient neoplasia
Abstract
The succinate dehydrogenase (SDH) complex is a key respiratory enzyme composed of four subunits: SDHA, SDHB, SDHC and SDHD. Remarkably, immunohistochemistry for SDHB becomes negative whenever there is bi‐alleic inactivation of any component of SDH, which is very rare in the absence of syndromic disease. Therefore, loss of SDHB immunohistochemistry serves as a marker of syndromic disease, usually germline mutation of one of the SDH subunits. Tumours which show loss of SDHB expression are termed succinate dehydrogenase‐deficient. In addition to loss of SDHB, tumours associated with SDHA mutation also show loss of SDHA expression. Fifteen per cent of pheochromocytoma and paraganglioma (PHEO/PGL) are associated with germline SDH mutation, and therefore SDH‐deficient. We recommend screening SDHB immunohistochemistry for all PHEO/PGL. SDH‐deficient gastrointestinal stromal tumours (GISTs) show distinctive features, including absent KIT proto‐oncogene receptor tyrosine kinase/platelet‐derived growth factor receptor A (KIT/PDGFRA) mutations [but positive staining for cKIT and DOG1], virtually exclusive gastric location, lobulated growth, multi‐focality, a prognosis not predicted by size and mitotic rate, frequent metastasis to lymph nodes and primary resistance to imatinib therapy. Thirty per cent are associated with SDHA germline mutation and 50% are associated with SDHC epimutation (post‐zygotic promoter hypermethylation) – the hallmark of the syndromic but non‐hereditary Carney triad (SDH‐ deficient GIST, SDH‐deficient paraganglioma and pulmonary chondroma). SDH‐deficient renal carcinoma is newly recognized under the World Health Organization (WHO) 2016 classification and shows vacuolated eosinophilic cytoplasmic and cytoplasmic inclusions. It is particularly associated with SDHB mutation, although SDHC and SDHA mutation occur. SDH‐deficient pituitary adenomas are recognized, but appear to be the least common SDH‐deficient neoplasm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Targeting metabolic transformation for cancer therapy
Tennant, D. A., Durán, R. V., & Gottlieb, E. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2817 · Cited by 1,059
Whole-genome landscape of pancreatic neuroendocrine tumours
Initiative, A. P. C. G., Scarpa, A., Chang, D. K., Nones, K., Corbo, V., Patch, A.-M., Bailey, P., Lawlor, R. T., Johns, A. L., Miller, D. K., et al. (2017) · Nature · doi:10.1038/nature21063 · Cited by 999
Self-citationSDHA is a tumor suppressor gene causing paraganglioma
Burnichon, N., Brière, J.-J., Libé, R., Vescovo, L., Rivière, J., Tissier, F., Jouanno, E., Jeunemaitre, X., Bénit, P., Tzagoloff, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq206 · Cited by 650
Janeway, K. A., Kim, S. Y., Lodish, M., Nosé, V., Rustin, P., Gaal, J., Dahia, P. L. M., Liegl, B., Ball, E. R., Raygada, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009199108 · Cited by 628
Clinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma Syndromes
Benn, D. E., Gimenez-Roqueplo, A.-P., Reilly, J. R., Bertherat, J., Burgess, J., Byth, K., Croxson, M., Dahia, P. L. M., Elston, M., Gimm, O., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1862 · Cited by 570
van Nederveen, F. H., Gaal, J., Favier, J., Korpershoek, E., Oldenburg, R. A., de Bruyn, E. M., Sleddens, H. F., Derkx, P., Rivière, J., Dannenberg, H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70164-0 · Cited by 538
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
Comino-Méndez, I., Gracia-Aznárez, F. J., Schiavi, F., Landa, I., Leandro-García, L. J., Letón, R., Honrado, E., Ramos-Medina, R., Caronia, D., Pita, G., et al. (2011) · Nature Genetics · doi:10.1038/ng.861 · Cited by 526
Miettinen, M., Wang, Z.-F., Sarlomo-Rikala, M., Osuch, C., Rutkowski, P., & Lasota, J. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182260752 · Cited by 363
Gill, A. J., Hes, O., Papathomas, T., Šedivcová, M., Tan, P. H., Agaimy, A., Andresen, P. A., Kedziora, A., Clarkson, A., Toon, C. W., et al. (2014) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000292 · Cited by 347
Self-citationRicketts, C. J., Forman, J. R., Rattenberry, E., Bradshaw, N., Lalloo, F., Izatt, L., Cole, T. R., Armstrong, R., Kumar, V. K. A., Morrison, P. J., et al. (2010) · Human Mutation · doi:10.1002/humu.21136 · Cited by 337
PHD2 Mutation and Congenital Erythrocytosis with Paraganglioma
Ladroue, C., Carcenac, R., Leporrier, M., Gad, S., Le Hello, C., Galateau-Salle, F., Feunteun, J., Pouysségur, J., Richard, S., & Gardie, B. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806277 · Cited by 323
Korpershoek, E., Favier, J., Gaal, J., Burnichon, N., van Gessel, B., Oudijk, L., Badoual, C., Gadessaud, N., Venisse, A., Bayley, J.-P., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1043 · Cited by 277
Gill, A. J., Benn, D. E., Chou, A., Clarkson, A., Muljono, A., Meyer-Rochow, G. Y., Richardson, A. L., Sidhu, S. B., Robinson, B. G., & Clifton-Bligh, R. J. (2010) · Human Pathology · doi:10.1016/j.humpath.2009.12.005 · Cited by 277
Self-citationGimm, O., Armanios, M. Y., Dziema, H., Neumann, H. P. H., & Eng, C. (2000) · PubMed · Cited by 274
Pasini, B., & Stratakis, C. A. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02111.x · Cited by 273
Trpkov, K., Hes, O., Agaimy, A., Bonert, M., Martinek, P., Magi-Galluzzi, C., Kristiansen, G., Lüders, C., Nesi, G., Compérat, E., et al. (2016) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000617 · Cited by 255
Self-citationHereditary paraganglioma targets diverse paraganglia: Table 1
Baysal, B. E. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.9.617 · Cited by 235
Gatta-Cherifi, B., Chabre, O., Murat, A., Niccoli, P., Cardot-Bauters, C., Rohmer, V, Young, J., Delemer, B., Du Boullay, H., Verger, M. F., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0679 · Cited by 230
Papathomas, T. G., Oudijk, L., Persu, A., Gill, A. J., van Nederveen, F., Tischler, A. S., Tissier, F., Volante, M., Matias-Guiu, X., Smid, M., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.41 · Cited by 227
Self-citationWilliamson, S. R., Eble, J. N., Amin, M. B., Gupta, N. S., Smith, S. C., Sholl, L. M., Montironi, R., Hirsch, M. S., & Hornick, J. L. (2015) · Modern Pathology · doi:10.1038/modpathol.2014.86 · Cited by 225
Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types
Gill, A. J., Chou, A., Vilain, R., Clarkson, A., Lui, M., Jin, R., Tobias, V., Samra, J., Goldstein, D., Smith, C., et al. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181d6150d · Cited by 218
Self-citationSuccinate dehydrogenase (SDH) and mitochondrial driven neoplasia
Gill, A. J. (2012) · Pathology · doi:10.1097/pat.0b013e3283539932 · Cited by 215
Self-citationUgalde, C. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh071 · Cited by 215
Gaal, J., Stratakis, C. A., Carney, J. A., Ball, E. R., Korpershoek, E., Lodish, M. B., Levy, I., Xekouki, P., van Nederveen, F. H., den Bakker, M. A., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.185 · Cited by 212
15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1–5
Benn, D. E., Robinson, B. G., & Clifton-Bligh, R. J. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0268 · Cited by 197
King, K. S., Prodanov, T., Kantorovich, V., Fojo, T., Hewitt, J. K., Zacharin, M., Wesley, R., Lodish, M., Raygada, M., Gimenez-Roqueplo, A.-P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.6353 · Cited by 196
Miettinen, M., Killian, J. K., Wang, Z.-F., Lasota, J., Lau, C., Jones, L., Walker, R., Pineda, M., Zhu, Y. J., Kim, S. Y., et al. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182671178 · Cited by 195
Recurrent epimutation of SDHC in gastrointestinal stromal tumors
Killian, J. K., Miettinen, M., Walker, R. L., Wang, Y., Zhu, Y. J., Waterfall, J. J., Noyes, N., Retnakumar, P., Yang, Z., Smith, W. I., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009961 · Cited by 193
Whole-Exome Sequencing Identifies MDH2 as a New Familial Paraganglioma Gene
Cascón, A., Comino-Méndez, I., Currás-Freixes, M., de Cubas, A. A., Contreras, L., Richter, S., Peitzsch, M., Mancikova, V., Inglada-Pérez, L., Pérez-Barrios, A., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv053 · Cited by 192
Renal Tumors Associated With Germline SDHB Mutation Show Distinctive Morphology
Gill, A. J., Pachter, N. S., Chou, A., Young, B., Clarkson, A., Tucker, K. M., Winship, I. M., Earls, P., Benn, D. E., Robinson, B. G., et al. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318227e7f4 · Cited by 191
Self-citationAberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad
Haller, F., Moskalev, E. A., Faucz, F. R., Barthelmeß, S., Wiemann, S., Bieg, M., Assie, G., Bertherat, J., Schaefer, I.-M., Otto, C., et al. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-14-0254 · Cited by 189
Germline FH Mutations Presenting With Pheochromocytoma
Clark, G. R., Sciacovelli, M., Gaude, E., Walsh, D. M., Kirby, G., Simpson, M. A., Trembath, R. C., Berg, J. N., Woodward, E. R., Kinning, E., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1659 · Cited by 177
A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma
Lorenzo, F. R., Yang, C., Ng Tang Fui, M., Vankayalapati, H., Zhuang, Z., Huynh, T., Grossmann, M., Pacak, K., & Prchal, J. T. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0967-z · Cited by 171
Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) – A review
Miettinen, M., & Lasota, J. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.05.033 · Cited by 168
Bayley, J.-P., van Minderhout, I., Weiss, M. M., Jansen, J. C., Oomen, P. H., Menko, F. H., Pasini, B., Ferrando, B., Wong, N., Alpert, L. C., et al. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-1 · Cited by 166
Xekouki, P., Pacak, K., Almeida, M., Wassif, C. A., Rustin, P., Nesterova, M., de la Luz Sierra, M., Matro, J., Ball, E., Azevedo, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1179 · Cited by 164
Xekouki, P., Szarek, E., Bullova, P., Giubellino, A., Quezado, M., Mastroyannis, S. A., Mastorakos, P., Wassif, C. A., Raygada, M., Rentia, N., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4297 · Cited by 159
Yang, C., Zhuang, Z., Fliedner, S. M. J., Shankavaram, U. T., Sun, M. G., Bullova, P., Zhu, R., ELKAHLOUN, A. G., Kourlas, P. J., Merino, M. J., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1205-7 · Cited by 153
Fumarate Hydratase–deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings
Harrison, W. J., Andrici, J., Maclean, F. M., Ghahan, R. M., Farzin, M., Sioson, L., Toon, C. W., Clarkson, A., Watson, N., Pickett, J., et al. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000573 · Cited by 152
Self-citationTubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci
Smith, S. C., Trpkov, K., Chen, Y., Mehra, R., Sirohi, D., Ohe, C., Cani, A. K., Hovelson, D. H., Omata, K., McHugh, J. B., et al. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000719 · Cited by 150
Self-citationA germline mutation of the KIF1Bβ gene on 1p36 in a family with neural and nonneural tumors
Yeh, I., Lenci, R., Qin, Y., Buddavarapu, K., Ligon, A. H., Leteurtre, E., Cao, C. D., Cardot-Bauters, C., Pigny, P., & Dahia, P. L. M. (2008) · Human Genetics · doi:10.1007/s00439-008-0553-1 · Cited by 149
Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors
Wagner, A. J., Remillard, S. P., Zhang, Y., Doyle, L. A., George, S., & Hornick, J. L. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.153 · Cited by 141
Dwight, T., Benn, D. E., Clarkson, A., Vilain, R. E., Lipton, L. R., Robinson, B. G., Clifton-Bligh, R. J., & Gill, A. J. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182671155 · Cited by 119
Self-citationFamilial SDHA Mutation Associated With Pituitary Adenoma and Pheochromocytoma/Paraganglioma
Dwight, T., Mann, K., Benn, D. E., Robinson, B. G., McKelvie, P. A., Gill, A. J., Winship, I., & Clifton-Bligh, R. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1400 · Cited by 118
Self-citationSmith, S. C., Sirohi, D., Ohe, C., McHugh, J. B., Hornick, J. L., Kalariya, J. J., Karia, S., Snape, K. M. G., Hodgson, S. V., Cani, A. K., et al. (2017) · Histopathology · doi:10.1111/his.13183 · Cited by 114
Renal Tumors and Hereditary Pheochromocytoma-Paraganglioma Syndrome Type 4
Gill, A. J., Pachter, N., Clarkson, A., Tucker, K., Winship, I., Benn, D. E., Robinson, B. G., & Clifton-Bligh, R. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1012357 · Cited by 106
Self-citationXekouki, P., & Stratakis, C. A. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0118 · Cited by 100
Succinate Dehydrogenase Deficiency Is Rare in Pituitary Adenomas
Gill, A. J., Toon, C. W., Clarkson, A., Sioson, L., Chou, A. S. Y., Winship, I., Robinson, B. G., Benn, D. E., Clifton-Bligh, R. J., & Dwight, T. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000149 · Cited by 89
Self-citationRecent advances in the genetics of SDH-related paraganglioma and pheochromocytoma
Hensen, E. F., & Bayley, J. (2010) · Familial Cancer · doi:10.1007/s10689-010-9402-1 · Cited by 85
Niemeijer, N. D., Papathomas, T. G., Korpershoek, E., de Krijger, R. R., Oudijk, L., Morreau, H., Bayley, J., Hes, F. J., Jansen, J. C., Dinjens, W. N. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2689 · Cited by 81
Mason, E. F., & Hornick, J. L. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000685 · Cited by 81
A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling
Yakirevich, E., Ali, S. M., Mega, A. E., McMahon, C., Brodsky, A. S., Ross, J. S., Allen, J. M., Elvin, J. A., Safran, H. P., & Resnick, M. B. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000403 · Cited by 71
Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression
Chou, A. S. Y., Chen, J., Clarkson, A., Samra, J. S., Clifton-Bligh, R. J., Hugh, T. J., & Gill, A. J. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.77 · Cited by 56
Self-citationEpigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas
Richter, S., Klink, B., Nacke, B., de Cubas, A. A., Mangelis, A., Rapizzi, E., Meinhardt, M., Skondra, C. D., Mannelli, M., Robledo, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3856 · Cited by 53
Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma
Gill, A. J., Lipton, L. R., Taylor, J., Benn, D. E., Richardson, A. L., Frydenberg, M., Shapiro, J., Clifton-Bligh, R. J., Chow, C. W., & Bogwitz, M. R. (2013) · Pathology · doi:10.1097/pat.0000000000000018 · Cited by 53
Self-citationÖzlük, Y., Taheri, D., Matoso, A., Şanlı, Ö., Berker, N. K., Yakirevich, E., Balasubramanian, S., Ross, J. S., Ali, S. M., & Netto, G. J. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.07.027 · Cited by 51
“Pediatric-Type” Gastrointestinal Stromal Tumors Are SDHB Negative (“Type 2”) GISTs
Gill, A. J., Chou, A. S. Y., Vilain, R. E., & Clifton-Bligh, R. J. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182217b93 · Cited by 51
Self-citationSousa, S. M. C. D., McCabe, M. J., Wu, K. H. C., Roscioli, T., Gayevskiy, V., Brook, K., Rawlings, L. H., Scott, H. S., Thompson, T. J., Earls, P., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0944 · Cited by 46
Self-citationUniversal Genetic Screening Uncovers a Novel Presentation of an SDHAF2 Mutation
Casey, R. T., Garrahy, A., Tuthill, A., O’Halloran, D., Joyce, C. M., Casey, M. B., O’Shea, P. M., & Bell, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4536 · Cited by 42
SDHC mutation in an elderly patient without familial antecedents
López-Jiménez, E. A., de Campos, J. M., Kusak, E., Landa, I., Leskelä, S., Montero‐Conde, C., Leandro-Garcia, L. J., Vallejo, L. A., Madrigal, B., Rodríguez‐Antona, C., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03368.x · Cited by 41
Utility of the succinate:fumarate ratio for assessing SDH dysfunction in different tumor types
Kim, E., Wright, M. J., Sioson, L., Novos, T., Gill, A. J., Benn, D. E., White, C., Dwight, T., & Clifton-Bligh, R. J. (2016) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2016.12.006 · Cited by 41
Self-citationMapping of Succinate Dehydrogenase Losses in 2258 Epithelial Neoplasms
Miettinen, M., Sarlomo‐Rikala, M., McCue, P. A., Czapiewski, P., Langfort, R., Waloszczyk, P., Ważny, K., Biernat, W., Lasota, J. P., & Wang, Z. (2013) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e31828bfdd3 · Cited by 39
Jiang, Q., Zhang, Y., Zhou, Y., Hou, Y., Wang, J., Li, J., Li, M., Tong, H., & Lu, W. (2015) · PubMed · Cited by 39
Paik, J. Y., Toon, C. W., Benn, D. E., High, H. A., Hasovitz, C., Pavlakis, N., Clifton-Bligh, R. J., & Gill, A. J. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.2647 · Cited by 35
Self-citationGenetic Analyses of Apparently Sporadic Pheochromocytomas: The Rotterdam Experience
Korpershoek, E., van Nederveen, F. H., Dannenberg, H., Petri, B., Komminoth, P., Perren, A. A., Lenders, J. W. M., Verhofstad, A. A. J., de Herder, W. W., de Krijger, R. R., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.014 · Cited by 32
Pacák, K., Chew, E. Y., Pappo, A. S., Yang, C., Lorenzo, F., Wilson, M. W., Aronow, M. E., Young, J. A., POPOVIC, V. M., & Zhuang, Z. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.06.019 · Cited by 32
A MEN1 syndrome with a paraganglioma
Jamilloux, Y., Favier, J., Pertuit, M., Delage-Corre, M., Lopez, S., Teissier, M. P., Mathonnet, M., Galinat, S., Barlier, A., & Archambeaud, F. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.128 · Cited by 32
Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma
Cornejo, K. M., Lu, M., Yang, P., Wu, S., Cai, C., Zhong, W., Olumi, A. F., Young, R. H., & Wu, C. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.02.013 · Cited by 30
A Duodenal SDH-Deficient Gastrointestinal Stromal Tumor in a Patient With a Germline SDHB Mutation
Elston, M. S., Sehgal, S., Dray, M. S., Phillips, E., Conaglen, J. V., Clifton-Bligh, R. J., & Gill, A. J. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00165 · Cited by 22
Self-citationScreening for ovarian cancer is not effective
Siva, N. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70259-0 · Cited by 7
Cited by
The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives
Sbaraglia, M., Bellan, E., & Dei Tos, A. P. (2020) · Pathologica · doi:10.32074/1591-951x-213 · Cited by 1,135
Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas
Mete, O., Asa, S. L., Gill, A. J., Kimura, N., de Krijger, R. R., & Tischler, A. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09704-6 · Cited by 424
Self-citationSynthetic lethal therapies for cancer: what’s next after PARP inhibitors?
Ashworth, A., & Lord, C. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0055-6 · Cited by 420
Mitochondrial disorders of the OXPHOS system
Fernandez‐Vizarra, E., & Zeviani, M. (2021) · FEBS Letters · doi:10.1002/1873-3468.13995 · Cited by 305
Trpkov, K., Hes, O., Williamson, S. R., Adeniran, A. J., Agaimy, A., Alaghehbandan, R., Amin, M. B., Argani, P., Chen, Y.-B., Cheng, L., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00779-w · Cited by 258
Self-citation
Metadata
- Authors
- Gill, A. J.
- Venue
- Histopathology
- Publisher
- Wiley
- Published
- 2017-12-14
- Volume
- 72
- Issue
- 1
- Pages
- 106-116
- ISSN
- 0309-0167 (ISSN-L)
- 1365-2559
- OpenAlex
- W2774342415
- Cited by
- 256
- References
- 72
- FWCI
- 19.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.